Search

Home > New FDA Approvals > 088 - Arterys onco imaging platform; First AI triage software approval; Trevo clot removal device expanded indication; orphan drug designation for necrotizing enterocolitis drug; Scott Gottlieb statements on flu vaccine efficacy and novel treatments for n
Podcast: New FDA Approvals
Episode:

088 - Arterys onco imaging platform; First AI triage software approval; Trevo clot removal device expanded indication; orphan drug designation for necrotizing enterocolitis drug; Scott Gottlieb statements on flu vaccine efficacy and novel treatments for n
Category: Science & Medicine
Duration: 00:15:36
Publish Date: 2018-02-16 07:00:00
Description:

February 16, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

1:49 Arterys Receives First FDA Clearance for Broad Oncology Imaging in Deep Learning  https://www.prnewswire.com/news-releases/arterys-receives-first-fda-clearance-for-broad-oncology-imaging-suite-with-deep-learning-300599275.html

4:24 Viz.ai granted de novo FDA clearance for first artificial intelligence triage software https://www.prnewswire.com/news-releases/vizai-granted-de-novo-fda-clearance-for-first-artificial-intelligence-triage-software-300599381.html

6:54 Stryker's Trevo® Retriever becomes first and only device indicated for treatment up to 24 hours, aligning with new AHA/ASA guidelines https://www.prnewswire.com/news-releases/strykers-trevo-retriever-becomes-first-and-only-device-indicated-for-treatment-up-to-24-hours-aligning-with-new-ahaasa-guidelines-300599682.html https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm596983.htm

8:41 Prometic granted orphan drug designation by FDA for Inter-Alpha-Inhibitor-Proteins for treatment of necrotizing enterocolitis (NEC) https://www.prnewswire.com/news-releases/prometic-granted-orphan-drug-designation-by-fda-for-inter-alpha-inhibitor-proteins-for-treatment-of-necrotizing-enterocolitis-nec-674162503.html

10:21 Statement from FDA Commissioner Scott Gottlieb, M.D. on the efficacy of the 2017-2018 influenza vaccine https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm597077.htm

12:35 Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA’s new drug review programs https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm596897.htm

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0